The novel ATR inhibitor VE-821 selectively sensitizes pancreatic cancer cells to radiation and chemotherapy

被引：0
|
作者：
Fokas, E. [1 ]
Prevo, R. [1 ]
Reaper, P. [2 ]
Charlton, P. [2 ]
Pollard, J. [2 ]
McKenna, W. G. [1 ]
Muschel, R. [1 ]
Brunner, T. [1 ]
机构：
[1] Univ Oxford, Dept Oncol, Gray Inst Radiat Oncol & Biol, Oxford, England
[2] Vertex Pharmaceut Europe Ltd Abingdon, Oxford, England
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2012年 / 188卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：115 / 116
页数：2
相关论文
共 50 条
  • [1] The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy
    Prevo, Remko
    Fokas, Emmanouil
    Reaper, Philip M.
    Charlton, Peter A.
    Pollard, John R.
    McKenna, W. Gillies
    Muschel, Ruth J.
    Brunner, Thomas B.
    CANCER BIOLOGY & THERAPY, 2012, 13 (11) : 1072 - 1081
  • [2] The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin
    Su, Haochen
    Yuan, Yue
    Tang, Jiatong
    Zhang, Yixuan
    Wu, Hao
    Zhang, Yin
    Liang, Jiawei
    Wang, Lei
    Zou, Xiaoping
    Huang, Shuling
    Zhang, Shu
    Lv, Ying
    TRANSLATIONAL ONCOLOGY, 2023, 36
  • [3] ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
    Fokas, E.
    Prevo, R.
    Pollard, J. R.
    Reaper, P. M.
    Charlton, P.
    Cornelissen, B.
    Vallis, K.
    Hammond, E. M.
    Olcina, M. M.
    McKenna, W. G.
    Muschel, R. J.
    Brunner, T. B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 41 - 41
  • [4] The Combination of the PARP Inhibitor Olaparib and the ATR Inhibitor VE-821 Selectively Targets ATM-Deficient Lung Cancer Cells
    Jette, N.
    Radhamani, S.
    Arthur, G.
    Ye, R.
    Goutam, S.
    Boylos, A.
    Petersen, L.
    Bose, P.
    Bebb, G.
    Lees-Miller, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S570 - S571
  • [5] VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation
    Fujisawa, Hiroshi
    Nakajima, Nakako Izumi
    Sunada, Shigeaki
    Lee, Younghyun
    Hirakawa, Hirokazu
    Yajima, Hirohiko
    Fujimori, Akira
    Uesaka, Mitsuru
    Okayasu, Ryuichi
    RADIATION ONCOLOGY, 2015, 10
  • [6] Synergistic potentiation of (-)-lomaiviticin A cytotoxicity by the ATR inhibitor VE-821
    Colis, Laureen C.
    Herzon, Seth B.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (13) : 3122 - 3126
  • [7] Chemosensitisation By, and Single Agent Activity of, ATR Inhibitor VE-821 in Human Breast Cancer Cells
    Middleton, F. K.
    Chen, T.
    Pollard, J. R.
    Curtin, N. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 85 - 86
  • [8] VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation
    Hiroshi Fujisawa
    Nakako Izumi Nakajima
    Shigeaki Sunada
    Younghyun Lee
    Hirokazu Hirakawa
    Hirohiko Yajima
    Akira Fujimori
    Mitsuru Uesaka
    Ryuichi Okayasu
    Radiation Oncology, 10
  • [9] The ATR inhibitor VE-821 in combination with the novel topoisomerase I inhibitor LMP-400 selectively kills cancer cells by disabling DNA replication initiation and fork elongation
    Josse, Rozenn
    Martin, Scott E.
    Guha, Rajarshi
    Ormanoglu, Pinar
    Pfister, Thomas
    Morris, Joel
    Doroshow, James H.
    Pommier, Yves
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Preclinical evaluation of the ATR inhibitor VE-821 alone and in combination with the PARP inhibitor olaparib in neuroblastoma
    Southgate, H.
    Chen, L.
    Curtin, N. J.
    Tweddle, D. A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E31 - E31
12345